|
市場調査レポート
商品コード
1541025
尿管ステント市場レポート：製品タイプ、材料、用途、最終用途、地域別 2024-2032Ureteral Stents Market Report by Product Type, Material, Application, End Use (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), and Region 2024-2032 |
||||||
カスタマイズ可能
|
|||||||
| 尿管ステント市場レポート：製品タイプ、材料、用途、最終用途、地域別 2024-2032 |
|
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 144 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
尿管ステント市場の世界市場規模は、2023年に3億7,490万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに6億650万米ドルに達し、2024年から2032年の間に5.3％の成長率（CAGR）を示すと予測しています。泌尿器疾患の有病率の増加、ステント技術における新たな技術進歩、尿管ステントの採用を奨励する有利な政府政策の実施は、市場成長の主な要因の一部です。
尿管ステントは、シリコーンやポリウレタンなどの医療グレードの材料で作られた小型の柔軟なチューブで、泌尿器科でさまざまな尿路疾患の管理に使用されます。腎臓と膀胱をつなぐ管である尿管に挿入します。閉塞の緩和、治癒の促進、腎臓の排出など、さまざまな目的に使用されます。腎結石、腫瘍、その他の閉塞による尿管の閉塞を緩和します。尿管の開通を維持し、尿が腎臓から膀胱へ自由に流れるようにすることで、合併症を予防します。また、一時的なもので、定期的なモニタリングと除去が必要であり、泌尿器系のケアに不可欠で、泌尿器系の健康と機能性を確保します。
この市場は、主に泌尿器科の技術的進歩によって牽引されています。さらに、より効果的で低侵襲な尿管ステントデバイスの市場開拓が市場成長に影響を与えています。また、最新のステントは生体適合性が改善され、包埋が減少し、患者の快適性が向上しています。その結果、ヘルスケア専門家はこれらの先進的なステントを推奨し、利用する傾向が強まり、市場成長の原動力となっています。さらに、腎結石、尿路感染症（UTI）、尿管狭窄などの泌尿器科疾患の増加も、製品採用を加速させています。これらの疾患では、治療の一環として尿管ステントの挿入が必要となることが多いです。このほか、泌尿器系の問題にかかりやすい老年人口の増加が市場の成長に寄与しています。これとともに、泌尿器科疾患とその治療オプションに関する意識の高まりが早期診断と早期介入につながり、患者が医療アドバイスと治療を求めることを可能にし、市場成長を後押ししています。
尿管ステント市場動向/促進要因：
泌尿器科疾患の有病率の増加
泌尿器系疾患の増加により、市場は大きな影響を受けています。また、腎結石の増加は、腎臓または尿路に固形物が形成され、尿管を閉塞することで特徴付けられる一般的な泌尿器疾患であり、激しい痛みと潜在的な腎臓障害の原因となります。また、このような症例において、閉塞を緩和し尿の流れを促進する尿管ステントの使用が増加しており、より侵襲的な処置を回避しながら患者に救済を提供していることが、市場の成長を増大させています。さらに、高齢者人口の増加により、尿路感染症、膀胱問題、前立腺肥大症（BPH）などの泌尿器科疾患にかかりやすくなっています。これらの疾患は尿管閉塞や合併症につながる可能性があり、診断や治療の目的でステントを使用する必要があります。さらに、泌尿器科疾患に対する認識が向上し、診断技術が進歩したことで、早期発見・早期介入が可能になり、製品採用が加速しています。
ステントにおける新たな技術的進歩
尿管ステントの有効性を改善し、患者の快適性と転帰を向上させる重要な進歩や技術革新が市場を牽引しています。さらに、従来のステントは通常、非生分解性材料から製造されており、除去のために再手術が必要でした。そのため、生分解性ステントが採用されるようになり、時間の経過とともに体内で徐々に溶解するため、除去処置の必要性がなくなり、患者の不快感も軽減されるようになった。さらに、薬剤溶出技術を取り入れることで、尿管内にゆっくりと放出される薬剤でコーティングされたステントは、炎症や感染症などの合併症の予防に役立ち、副作用を最小限に抑え、ステントの治療効果を高める。これに加えて、3次元（3D）プリンティング技術の統合はステントの設計を一変させ、患者固有の解剖学的構造に合わせたカスタムメイドのステントを作ることを可能にします。
有利な政府政策の実施
尿管ステントの採用を奨励する有利な政府政策の実施は、市場の成長に影響を与えています。これらの政策は、ヘルスケアへのアクセス、患者の転帰、費用対効果を改善しています。さらに、政府の取り組みには、啓発キャンペーンや医療費助成プログラムなどがあり、ステントを患者に利用しやすくすることで、泌尿器科疾患の早期診断と治療が可能になり、市場成長に影響を与えています。さらに、医療機器分野の研究開発（R&D）に対して財政的インセンティブや助成金を提供する有利な政策もあり、これも成長を促す大きな要因となっています。また、企業はより効果的で、快適で、低侵襲な先進ステントの開発に投資しており、これが市場の成長を促進しています。これに加えて、政府の取り組みが新規参入を促し、患者のニーズや嗜好に応じた数多くのステント選択肢を生み出し、市場の成長を加速させています。
目次
第1章 序文
第2章 調査範囲と調査手法
- 調査の目的
- ステークホルダー
- データソース
- 一次情報
- 二次情報
- 市場推定
- ボトムアップアプローチ
- トップダウンアプローチ
- 調査手法
第3章 エグゼクティブサマリー
第4章 イントロダクション
- 概要
- 主要業界動向
第5章 世界の尿管ステント市場
- 市場概要
- 市場実績
- COVID-19の影響
- 市場予測
第6章 市場内訳：製品タイプ別
- オープンエンドステント
- 市場動向
- 市場予測
- クローズドエンドステント
- 市場動向
- 市場予測
- ダブルJステント
- 市場動向
- 市場予測
- マルチループステント
- 市場動向
- 市場予測
第7章 市場内訳：材料別
- 金属尿管ステント
- 市場動向
- 市場予測
- ポリマー尿管ステント
- 市場動向
- 主な種類
- シリコンステント
- ポリウレタンステント
- ハイブリッドステント
- 市場予測
第8章 市場内訳：用途別
- 腎臓結石
- 市場動向
- 市場予測
- 腎臓移植
- 市場動向
- 市場予測
- 腫瘍
- 市場動向
- 市場予測
- 尿失禁
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第9章 市場内訳：最終用途別
- 病院と診療所
- 市場動向
- 市場予測
- 外来手術センター（ASC）
- 市場動向
- 市場予測
- その他
- 市場動向
- 市場予測
第10章 市場内訳：地域別
- 北米
- 米国
- カナダ
- アジア太平洋地域
- 中国
- 日本
- インド
- 韓国
- オーストラリア
- インドネシア
- その他
- 欧州
- ドイツ
- フランス
- 英国
- イタリア
- スペイン
- ロシア
- その他
- ラテンアメリカ
- ブラジル
- メキシコ
- その他
- 中東・アフリカ
- 市場動向
- 市場内訳：国別
- 市場予測
第11章 SWOT分析
- 概要
- 強み
- 弱み
- 機会
- 脅威
第12章 バリューチェーン分析
第13章 ポーターのファイブフォース分析
- 概要
- 買い手の交渉力
- 供給企業の交渉力
- 競合の程度
- 新規参入業者の脅威
- 代替品の脅威
第14章 価格分析
第15章 競合情勢
- 市場構造
- 主要企業
- 主要企業のプロファイル
- Allium Medical Solutions Ltd.
- B. Braun Melsungen AG
- Biomerics
- Boston Scientific Corporation
- Becton Dickinson and Company
- Coloplast Ltd.
- Cook Group Incorporated
- Medline Industries Inc.
- Merit Medical Systems Inc.
- Olympus Corporation
- Teleflex Incorporated
List of Figures
- Figure 1: Global: Ureteral Stents Market: Major Drivers and Challenges
- Figure 2: Global: Ureteral Stents Market: Sales Value (in Million US$), 2018-2023
- Figure 3: Global: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 4: Global: Ureteral Stents Market: Breakup by Product Type (in %), 2023
- Figure 5: Global: Ureteral Stents Market: Breakup by Material (in %), 2023
- Figure 6: Global: Ureteral Stents Market: Breakup by Application (in %), 2023
- Figure 7: Global: Ureteral Stents Market: Breakup by End Use (in %), 2023
- Figure 8: Global: Ureteral Stents Market: Breakup by Region (in %), 2023
- Figure 9: Global: Ureteral Stents (Open End Stents) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 10: Global: Ureteral Stents (Open End Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 11: Global: Ureteral Stents (Closed End Stents) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Ureteral Stents (Closed End Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Ureteral Stents (Double J-Stents) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Ureteral Stents (Double J-Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Ureteral Stents (Multiloop Stents) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Ureteral Stents (Multiloop Stents) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Ureteral Stents (Metallic) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Ureteral Stents (Metallic) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Ureteral Stents (Polymer) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Ureteral Stents (Polymer) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Ureteral Stents (Kidney Stones) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Ureteral Stents (Kidney Stones) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Ureteral Stents (Kidney Transplantation) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Ureteral Stents (Kidney Transplantation) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Ureteral Stents (Tumors) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Ureteral Stents (Tumors) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Ureteral Stents (Urinary Incontinence) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Ureteral Stents (Urinary Incontinence) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Ureteral Stents (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Ureteral Stents (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Ureteral Stents (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Ureteral Stents (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Ureteral Stents (Ambulatory Surgical Centers-ASCs) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Ureteral Stents (Ambulatory Surgical Centers-ASCs) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Ureteral Stents (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Ureteral Stents (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: North America: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: North America: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: United States: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: United States: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Canada: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Canada: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Asia-Pacific: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Asia-Pacific: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: China: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: China: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 47: Japan: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 48: Japan: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 49: India: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 50: India: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 51: South Korea: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 52: South Korea: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 53: Australia: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 54: Australia: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 55: Indonesia: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 56: Indonesia: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 57: Others: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 58: Others: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 59: Europe: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 60: Europe: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 61: Germany: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 62: Germany: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 63: France: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 64: France: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 65: United Kingdom: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 66: United Kingdom: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 67: Italy: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 68: Italy: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 69: Spain: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 70: Spain: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 71: Russia: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 72: Russia: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 73: Others: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 74: Others: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 75: Latin America: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 76: Latin America: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 77: Brazil: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 78: Brazil: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 79: Mexico: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 80: Mexico: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 81: Others: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 82: Others: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 83: Middle East and Africa: Ureteral Stents Market: Sales Value (in Million US$), 2018 & 2023
- Figure 84: Middle East and Africa: Ureteral Stents Market: Breakup by Country (in %), 2023
- Figure 85: Middle East and Africa: Ureteral Stents Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 86: Global: Ureteral Stents Industry: SWOT Analysis
- Figure 87: Global: Ureteral Stents Industry: Value Chain Analysis
- Figure 88: Global: Ureteral Stents Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Ureteral Stents Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Ureteral Stents Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
- Table 3: Global: Ureteral Stents Market Forecast: Breakup by Material (in Million US$), 2024-2032
- Table 4: Global: Ureteral Stents Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 5: Global: Ureteral Stents Market Forecast: Breakup by End Use (in Million US$), 2024-2032
- Table 6: Global: Ureteral Stents Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 7: Global: Ureteral Stents Market: Competitive Structure
- Table 8: Global: Ureteral Stents Market: Key Players
The global ureteral stents market size reached US$ 374.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 606.5 Million by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032. The growing prevalence of urological disorders, emerging technological advances in stent technology, and the implementation of favorable government policies encouraging the adoption of ureteral stents are some of the major factors contributing to the market growth.
A ureteral stent is a small, flexible tube produced of medical-grade materials, such as silicone or polyurethane, used in urology to manage various urinary tract conditions. It is inserted into the ureter, the tube connecting the kidney to the bladder. It serves various purposes, including relieving obstruction, facilitating healing, and draining the kidney. It alleviates blockages in the ureter caused by kidney stones, tumors, or other obstructions. It keeps the ureter open, allowing urine to rush freely from the kidney to the bladder, preventing complications. Additionally, it is temporary, requires periodic monitoring and removal, and is essential in urological care, ensuring the health and functionality of the urinary system.
The market is primarily driven by the technological advancements in urology. In addition, the development of more effective and minimally invasive ureteral stent devices is influencing the market growth. Also, modern stents offer improved biocompatibility, reduced encrustation, and enhanced patient comfort. As a result, healthcare professionals are more inclined to recommend and utilize these advanced stents, driving the market growth. Moreover, the rising incidences of urological disorders such as kidney stones, urinary tract infections (UTI), and ureteral strictures are accelerating product adoption. These conditions often require the insertion of ureteral stents as part of their treatment. Besides this, the growing geriatric population susceptible to urological issues contributes to market growth. Along with this, the rising awareness about urological disorders and their treatment options led to earlier diagnosis and intervention, allowing patients to seek medical advice and treatment and propelling the market growth.
Ureteral Stents Market Trends/Drivers:
The growing prevalence of urological disorders
The market has witnessed a significant impact due to the growing incidences of urological disorders. In addition, the increasing number of kidney stones, is a common urological condition characterized by the formation of solid masses in the kidney or urinary tract that obstruct the ureter, causing severe pain and potential kidney damage is influencing the market growth. Also, the increasing use of ureteral stents in such cases to relieve obstruction and promote urine flow, offering patients relief while avoiding more invasive procedures is augmenting the market growth. Moreover, the growing geriatric population is more susceptible to urological disorders, including urinary tract infections, bladder issues, and benign prostatic hyperplasia (BPH). These conditions can lead to ureteral obstructions or complications, requiring the use of stents for diagnostic and therapeutic purposes. Furthermore, the improved awareness of urological disorders and advancements in diagnostic techniques led to early detection and intervention, which is accelerating the product adoption.
The emerging technological advances in stents
The market is driven by significant advancements and innovations improving the effectiveness of ureteral stents and enhancing patient comfort and outcomes. In addition, traditional stents are typically produced from non-biodegradable materials, requiring a second procedure for removal. It led to the adoption of biodegradable stents, gradually dissolving within the body over time, eliminating the need for removal procedures and reducing patient discomfort. Moreover, the incorporation of drug-eluting technology, stents coated with medications that can be slowly released into the ureter, helping to prevent complications such as inflammation or infections which minimizes side effects and enhances the stent's therapeutic effect representing another major growth-inducing factor. Besides this, the integration of three-dimensional (3D) printing technology transforms stent design and allows for the creation of custom-made stents tailored to a patient's unique anatomy which ensures a better fit, reducing irritation and discomfort, accelerating the market growth.
The implementation of favorable government policies
The implementation of favorable government policies encouraging the adoption of ureteral stents is influencing the market growth. These policies are improving healthcare accessibility, patient outcomes, and cost-effectiveness. In addition, government initiatives include awareness campaigns and subsidized healthcare programs, making stents accessible to patients, allowing early diagnosis and treatment of urological conditions which is influencing the market growth. Moreover, several favorable policies can provide financial incentives and grants for research and development (R&D) in the medical device sector, representing another major growth-inducing factor. Also, companies are investing in developing advanced stents that are more effective, comfortable, and minimally invasive, which is augmenting the market growth. Besides this, government initiatives are encouraging new market players to enter the market leading to numerous stent options, catering to several patient needs and preferences, thus accelerating the market growth.
Ureteral Stents Industry Segmentation:
IMARC Group provides an analysis of the key trends in each segment of the global ureteral stents market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, material, application and end use.
Breakup by Product Type:
Open End Stents
Closed End Stents
Double J-Stent
Multiloop Stents
Double J-stent represents the most popular product type
The report has provided a detailed breakup and analysis of the market based on the product type. This includes open-end stents, closed-end stents, double j-stent, and multiloop stents. According to the report, double j-stent accounted for the largest market share.
The double J-stent, also known as a double-pigtail stent, is a specialized product design characterized by its unique shape, which resembles the letter J with two curled ends. In addition, the double J-stent shape is optimized for stability and efficacy while the curled ends serve as anchors, securing the stent in place within the ureter, and influencing the market growth. It minimizes the risk of migration, where the stent may shift or dislodge from its intended position and ensures that the stent effectively facilitates urine drainage from the kidney to the bladder, preventing complications associated with ureteral obstructions.
Moreover, the double-pigtail shape reduces irritation and discomfort for patients and with improved patient comfort contributes to greater patient compliance and satisfaction, augmenting the market growth.
Besides this, the double J-stent is employed in clinical scenarios, from managing kidney stones and post-operative care to treating ureteral strictures which makes it a preferred choice for urologists and healthcare providers facing several patient needs.
Breakup by Material:
Metallic Ureteral Stents
Polymer Ureteral Stents
Silicone Stents
Polyurethane Stents
Hybrid Stents
Polymer ureteral stents presently account for the largest market share
A detailed breakup and analysis of the market based on the material has also been provided in the report. This includes metallic ureteral stents, polymer ureteral stents (silicone stents, polyurethane stents, and hybrid stents. According to the report, polymer ureteral stents accounted for the largest market share.
Polymer ureteral stents offer excellent biocompatibility and are well-tolerated by the body, minimizing the risk of allergic reactions or adverse tissue responses which makes them suitable for numerous patients, including those with sensitivities to other materials.
Moreover, polymer stents are highly flexible and can conform to the natural curvature of the ureter, allowing for a more comfortable placement procedure and reducing the risk of stent migration or discomfort for the patient which enables a better fit within the urinary tract, reducing the chances of irritation or obstruction.
Additionally, polymer ureteral stents are available in various sizes and configurations to cater to individual patient needs which ensures that urologists can select the most appropriate stent for each case, considering factors including the patient's anatomy and the specific urological condition.
Breakup by Application:
Kidney Stones
Kidney Transplantation
Tumors
Urinary Incontinence
Others
Kidney stones represent the largest market segment
A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes kidney stones, kidney transplantation, tumors, urinary incontinence, and others. According to the report, kidney stones accounted for the largest market share.
Kidney stones, medically known as nephrolithiasis or renal calculi, are a widespread urological issue affecting millions of individuals. These small, hard mineral and salt deposits can form in the kidneys and, when they move into the ureter, cause excruciating pain and block urine flow. In addition, the rising product demand for alleviating pain and facilitating the passage of kidney stones by inserting a stent into the ureter to act as a conduit, keeping the ureter open, and allowing the stone to pass more comfortably is influencing the market growth. It reduces pain and minimizes the risk of complications such as infection or kidney damage associated with prolonged blockage.
Additionally, the prevalence of kidney stones due to dietary habits, dehydration, and lifestyle choices is escalating the product demand for kidney stone management, contributing to the market growth.
Moreover, advancements in stent technology improved the efficacy of stents in this application with the development of biodegradable stents, drug-eluting stents, and 3D-printed stents which are more patient-friendly and effective in facilitating the passage of kidney stones, representing another major growth-inducing factor.
Breakup by End Use:
Hospitals and Clinics
Ambulatory Surgical Centers (ASCs)
Others
Hospitals and clinics dominate the market
A detailed breakup and analysis of the market based on the end use has also been provided in the report. This includes hospitals and clinics, ambulatory surgical centers (ASCs), and others. According to the report, hospitals and clinics accounted for the largest market share.
Hospitals and clinics serve as primary points of care for patients with urological issues. In addition, hospitals are equipped with advanced medical facilities and expert urologists, are well-positioned to provide comprehensive care, including the insertion and monitoring of stents, contributing to the market growth.
Moreover, hospitals and clinics have the infrastructure and expertise to perform complex urological procedures, such as the insertion and removal of stents which often require specialized equipment and highly trained medical staff that hospitals and clinics can easily provide, representing another major growth-inducing factor.
Apart from this, the availability of numerous stent types and sizes is essential in addressing several needs of patients. Hospitals and clinics typically maintain a comprehensive inventory of ureteral stents, allowing them to select the most appropriate stent for each patient's specific condition and anatomy.
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America leads the market, accounting for the majority of ureteral stents market
The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market.
The North America market is driven by the well-established healthcare infrastructure that promotes innovation and research. It offers world-renowned medical institutions, research centers, and urological experts which fosters a culture of continuous improvement, leading to the development and adoption of advanced technologies and treatments, including ureteral stents.
Moreover, the strong emphasis on patient care and comfort among healthcare providers aligning with the advancements in stent technology to enhance patient outcomes, represents another major growth-inducing factor. Patients in North America have access to the latest and most advanced medical treatments and devices, including advanced stents.
Along with this, North America's implementation of an enhanced regulatory framework ensures the safety and efficacy of medical devices, including ureteral stents, instilling confidence in healthcare professionals and patients regarding the reliability and performance of the products available in the market, propelling the market growth.
Competitive Landscape:
At present, key players in the market are actively implementing strategies to strengthen their positions and remain competitive in this dynamic healthcare segment. These strategies encompass various aspects, including innovation, partnerships, market expansion, and customer-centric approaches. They are investing in research and development (R&D) to create next-generation products including developing stents with advanced materials, drug-eluting capabilities, and improved designs to enhance patient comfort and reduce complications. Innovations such as smart stents with monitoring capabilities are also on the horizon. Moreover, several companies are entering strategic partnerships and collaborations with healthcare providers, research institutions, and academic centers which facilitate clinical trials, provide access to real-world patient data, and support the development of evidence-based solutions. Furthermore, key players are recognizing the importance of healthcare professionals and patients and focusing on customer-centric strategies involving comprehensive support services, including training for healthcare providers, educational resources for patients, and responsive customer service.
The market research report has provided a comprehensive analysis of the competitive landscape . Detailed profiles of all major companies have also been provided. Some of the key players in the market include:
Allium Medical Solutions Ltd.
B. Braun Melsungen AG
Biomerics
Boston Scientific Corporation
Becton, Dickinson and Company
Coloplast Ltd.
Cook Group Incorporated
Medline Industries Inc.
Merit Medical Systems Inc.
Olympus Corporation
Teleflex Incorporated
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Recent Developments:
In June 2022, Boston Scientific Corporation was recognized with a Bronze Edison Award in the Science and Medical category for its Tria Ureteral Stent, which is the first stent produced with a proprietary surface technology developed to offer protection against the accumulation of urine calcium and magnesium salt deposits.
In October 2020, Allium Medical Solutions Ltd., which specializes in minimally invasive technologies offer large markets with innovative solutions for clinical needs, announced that its urological stents received CE Mark for a new indication for treating urethral fistula after a successful trial.
In February 2023, Olympus Corporation, a global medtech company announced the acquisition of Taewoong Medical Co., Ltd, (Taewoong Medical), a Korea-based manufacturer of medical devices such as gastrointestinal (GI) metallic stents1 to strengthen its GI EndoTherapy product portfolio capabilities, enhancing patient outcome through comprehensive solutions.
Key Questions Answered in This Report
- 1. What was the size of the global ureteral stents market in 2023?
- 2. What is the expected growth rate of the global ureteral stents market during 2024-2032?
- 3. What has been the impact of COVID-19 on the global ureteral stents market?
- 4. What are the key factors driving the global ureteral stents market?
- 5. What is the breakup of the global ureteral stents market based on the product type?
- 6. What is the breakup of the global ureteral stents market based on the material?
- 7. What is the breakup of the global ureteral stents market based on the application?
- 8. What is the breakup of the global ureteral stents market based on the end use?
- 9. What are the key regions in the global ureteral stents market?
- 10. Who are the key players/companies in the global ureteral stents market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Ureteral Stents Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product Type
- 6.1 Open End Stents
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Closed End Stents
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Double J-Stents
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Multiloop Stents
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
7 Market Breakup by Material
- 7.1 Metallic Ureteral Stents
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Polymer Ureteral Stents
- 7.2.1 Market Trends
- 7.2.2 Major Types
- 7.2.2.1 Silicone Stents
- 7.2.2.2 Polyurethane Stents
- 7.2.2.3 Hybrid Stents
- 7.2.3 Market Forecast
8 Market Breakup by Application
- 8.1 Kidney Stones
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Kidney Transplantation
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Tumors
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Urinary Incontinence
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by End Use
- 9.1 Hospitals and Clinics
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Ambulatory Surgical Centers (ASCs)
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Region
- 10.1 North America
- 10.1.1 United States
- 10.1.1.1 Market Trends
- 10.1.1.2 Market Forecast
- 10.1.2 Canada
- 10.1.2.1 Market Trends
- 10.1.2.2 Market Forecast
- 10.1.1 United States
- 10.2 Asia-Pacific
- 10.2.1 China
- 10.2.1.1 Market Trends
- 10.2.1.2 Market Forecast
- 10.2.2 Japan
- 10.2.2.1 Market Trends
- 10.2.2.2 Market Forecast
- 10.2.3 India
- 10.2.3.1 Market Trends
- 10.2.3.2 Market Forecast
- 10.2.4 South Korea
- 10.2.4.1 Market Trends
- 10.2.4.2 Market Forecast
- 10.2.5 Australia
- 10.2.5.1 Market Trends
- 10.2.5.2 Market Forecast
- 10.2.6 Indonesia
- 10.2.6.1 Market Trends
- 10.2.6.2 Market Forecast
- 10.2.7 Others
- 10.2.7.1 Market Trends
- 10.2.7.2 Market Forecast
- 10.2.1 China
- 10.3 Europe
- 10.3.1 Germany
- 10.3.1.1 Market Trends
- 10.3.1.2 Market Forecast
- 10.3.2 France
- 10.3.2.1 Market Trends
- 10.3.2.2 Market Forecast
- 10.3.3 United Kingdom
- 10.3.3.1 Market Trends
- 10.3.3.2 Market Forecast
- 10.3.4 Italy
- 10.3.4.1 Market Trends
- 10.3.4.2 Market Forecast
- 10.3.5 Spain
- 10.3.5.1 Market Trends
- 10.3.5.2 Market Forecast
- 10.3.6 Russia
- 10.3.6.1 Market Trends
- 10.3.6.2 Market Forecast
- 10.3.7 Others
- 10.3.7.1 Market Trends
- 10.3.7.2 Market Forecast
- 10.3.1 Germany
- 10.4 Latin America
- 10.4.1 Brazil
- 10.4.1.1 Market Trends
- 10.4.1.2 Market Forecast
- 10.4.2 Mexico
- 10.4.2.1 Market Trends
- 10.4.2.2 Market Forecast
- 10.4.3 Others
- 10.4.3.1 Market Trends
- 10.4.3.2 Market Forecast
- 10.4.1 Brazil
- 10.5 Middle East and Africa
- 10.5.1 Market Trends
- 10.5.2 Market Breakup by Country
- 10.5.3 Market Forecast
11 SWOT Analysis
- 11.1 Overview
- 11.2 Strengths
- 11.3 Weaknesses
- 11.4 Opportunities
- 11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
- 13.1 Overview
- 13.2 Bargaining Power of Buyers
- 13.3 Bargaining Power of Suppliers
- 13.4 Degree of Competition
- 13.5 Threat of New Entrants
- 13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
- 15.1 Market Structure
- 15.2 Key Players
- 15.3 Profiles of Key Players
- 15.3.1 Allium Medical Solutions Ltd.
- 15.3.1.1 Company Overview
- 15.3.1.2 Product Portfolio
- 15.3.1.3 Financials
- 15.3.2 B. Braun Melsungen AG
- 15.3.2.1 Company Overview
- 15.3.2.2 Product Portfolio
- 15.3.2.3 SWOT Analysis
- 15.3.3 Biomerics
- 15.3.3.1 Company Overview
- 15.3.3.2 Product Portfolio
- 15.3.4 Boston Scientific Corporation
- 15.3.4.1 Company Overview
- 15.3.4.2 Product Portfolio
- 15.3.4.3 Financials
- 15.3.4.4 SWOT Analysis
- 15.3.5 Becton Dickinson and Company
- 15.3.5.1 Company Overview
- 15.3.5.2 Product Portfolio
- 15.3.5.3 Financials
- 15.3.5.4 SWOT Analysis
- 15.3.6 Coloplast Ltd.
- 15.3.6.1 Company Overview
- 15.3.6.2 Product Portfolio
- 15.3.6.3 Financials
- 15.3.6.4 SWOT Analysis
- 15.3.7 Cook Group Incorporated
- 15.3.7.1 Company Overview
- 15.3.7.2 Product Portfolio
- 15.3.8 Medline Industries Inc.
- 15.3.8.1 Company Overview
- 15.3.8.2 Product Portfolio
- 15.3.8.3 SWOT Analysis
- 15.3.9 Merit Medical Systems Inc.
- 15.3.9.1 Company Overview
- 15.3.9.2 Product Portfolio
- 15.3.9.3 Financials
- 15.3.9.4 SWOT Analysis
- 15.3.10 Olympus Corporation
- 15.3.10.1 Company Overview
- 15.3.10.2 Product Portfolio
- 15.3.10.3 Financials
- 15.3.10.4 SWOT Analysis
- 15.3.11 Teleflex Incorporated
- 15.3.11.1 Company Overview
- 15.3.11.2 Product Portfolio
- 15.3.11.3 Financials
- 15.3.11.4 SWOT Analysis
- 15.3.1 Allium Medical Solutions Ltd.
